Useful links to other organisations who support medical professionals working in haematology or who provide patient support.
Please note that the British Society for Haematology is not a patient body but a professional membership society staffed by administrators not doctors. Therefore we are unable to assist with individual patient queries.
the American Society of Hematology (ASH) serve both clinicians and scientists around the world who are working to conquer blood diseases. The Society's mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.
The British Blood Transfusion Society (BBTS) offers training and education programmes including Specialist Certificate qualifications as well as a Post-Grad Cert/Dipl/MSc in Advanced Specialist Blood Transfusion Practice. It also holds the UK's leading transfusion conference.
The British Society of Blood and Marrow Transplantation is an organisation for those with a professional interest in haematopoietic cell transplantation. For public interest, their site also contains a list of UK transplant centres and doctors available.
The objectives of the British Society for Haemostasis and Thrombosis are the advancement of public education and the promotion of all branches of medical science concerned with haemostasis and thrombosis. It is the main Academic Thrombosis & Haemostasis Society in the United Kingdom with over 300 members.
The European Hematology Association serve medical professionals, researchers, and scientists with an active interest in hematology. They are proud to be the largest European-based organization connecting hematologists worldwide to support career development and research, harmonize hematology education, and advocate for hematologists and hematology.
The European Reference Network on Rare Hematological Disorders (ERN-EuroBloodNet), launched by the European Commission in 2017, is a network formed by 66 nationally recognized healthcare providers in 15 Member States with the aim to facilitate the concentration of highly specialized expertise and services for the clinical management of patients affected by oncological and non-oncological rare haematological diseases, enhancing as a result the access to best quality of care to patients affected by rare hematological diseases.
The International Society of Geriatric Oncology, founded in 2000, aims to optimise the treatment of cancer in older adults. It does this through education, research and clinical practice.
The International Society of Blood Transfusion (ISBT) is an international network of medical professionals that is used to share knowledge about the practice of blood transfusion. Their website provides opportunities for members to get involved in e-working groups and provides access to webcasts captured at their Regional and International Congresses. It also features around 300 scientific guideline documents from 25 different countries and organisations.
The UK ITP forum, established in 2011, is a working group of health care professionals with a special interest in the care of patients with immune thrombocytopenia (ITP).
The Serious Hazards of Transfusion organisation collects and analyses information on adverse events and reactions in blood transfusion in the UK. They hope to improve long-term outcomes in patient care.
SCTSP aims to increase awareness by developing a comprehensive education and training programme for community groups, carers and health professionals. It promotes support, advice and co-ordination of care to individuals and families where there is a major haemoglobin disorder. The project acts as a specialist resource for other professionals and communities at risk and works closely with the Local/Healthy Authority departments and the voluntary sector to develop a coordinated service.
The Thalassaemia International Federation (TIF) Industry Circle, officially launched in 2012, is a network of pharmaceutical industries that share a common interest in haemoglobin disorders (thalassaemia and sickle cell disease) and in the development of technologies relating to their prevention, treatment and monitoring.
The European Society for Blood and Marrow Transplantation (EBMT) is a non-profit organisation, established in 1974, to give scientists and physicians involved in clinical bone marrow transplantation the opportunity to share experiences and develop co-operative studies.
The International Society on Thrombosis and Haemostasis (ISTH) is a global not-for-profit membership organization advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders.
Thrombosis UK is a leader in: Identifying, Informing & Partnering the NHS, healthcare providers and individuals to work to improve prevention of venous thromboembolism (VTE) and the management and care of unavoidable VTE events. Their priority is for everyone to know the Risks Signs & Symptoms of VTE and to support research to extend understanding into the prevention and Best Management of VTE.
This is a collection of professional guidelines aimed predominantly at hospital staff. Useful background information about the history of blood transfusion, the use of blood components and blood-borne diseases may be found on the site. E-learning modules are in development.
The UK Forum on Haemoglobin Disorders is a multi-disciplinary group of health care professionals interested in all aspects of sickle cell disease, thalassaemia and related conditions.
Developed by UK-based haematologists, this site is a comprehensive guide to laboratory haemostasis with comprehensive explanations, web links and exercises in data assessment. This will be a useful resource for the postgraduate as well as the undergraduate student.
The Medical Research Council invests in research on behalf of the UK taxpayer. They will consider projects across all disciplines of medicine, covering mental and physical health.
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world's leading cancer centers that is devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives.
The National Institute for Health and Care Excellence (NICE) produces evidence-based guidance used by the British National Health Service, and many other countries worldwide, to determine the best pathway of care for patients.
The National Cancer Research Institute was founded in 2001 to aid the collaboration between cancer research funders and form a UK-wide strategic partnership.
A database of systematic reviews and randomised controlled trials (updated monthly) relevant to transfusion medicine.
Focusing on blood cancer, the Anthony Nolan Trust provides information to patients and families about receiving a transplant and life after transplant. It also works closely with clinicians and transplant units to find and match patients to stem cell donors around the world.
Anticoagulation UK's mission can be defined by 3 key objectives: (1) Prevention of blood clots, (2) Providing information and education, (3) Promoting patient choice and independence
Blood Cancer UK are the UK’s specialist blood cancer charity. Founded in 1960, they have been working for over 50 years to improve patient care and conduct research into blood cancer.
Children’s Cancer and Leukaemia Group is a leading children’s cancer charity and the UK and Ireland’s professional association for those involved in the treatment and care of children with cancer.
Patient led UK charity whose mission is to support and empower Chronic Lymphocytic Leukaemia (CLL) patients, their families and their carers through education and access to reliable, relevant and current information.
A group of patients, carers, doctors, and scientists who are all interested in patients with rare inherited anaemia
DBA UK is a registered charity that delivers support to and conducts research for those living with Diamond Blackfan Anaemia. The charity has a telephone support line and holds an annual conference for patients, parents and carers.
DKMS UK are dedicated to the fight against blood cancer and blood disorders. Their mission is to provide a matching donor for every blood cancer patient in need of a blood stem cell donation. To make this happen they raise awareness, recruit and retain potential blood stem cell donors to provide a second chance of life, raise funds to match donor registration costs, and improve blood cancer therapies by their own research.
The Immune Thrombocytopenia Support Association is a UK charity promoting the welfare of those living with ITP. They recruit volunteer in-house medical advisers and offer patient and parental support by providing information, guidance for schools and 'listening ear' contact with volunteers.
Lymphoma Action, a registered UK charity, provides education and training for healthcare professionals and emotional support for patients and those living with Lymphoma. Their patient support offers a diverse range of options including a buddy scheme, support groups, a freephone helpline and a live chat service.
The UK Mastocytosis Support Group supports Mast Cell Disease patients so they can better understand their disease.
This organisation helps organise informal local and regional groups to enable patients to meet regularly face to face and support each other.
MPN Voice’s mission is to provide clear and accurate information and emotional support to everyone who has been diagnosed with a myeloproliferative neoplasm (MPN) and their families/friends.
The UK Myeloma Forum aims to improve the treatment of patients with myeloma by:
developing and promoting clinical trials of myeloma treatment and linked scientific studies
encouraging collaborative research in myeloma developing guidelines for the management of patients with myeloma promoting the education of healthcare professionals and patients in all aspects of the disease
Myeloma UK are a UK charity focusing on the discovery, development and access to new treatments for the condition. They provide support to patients and families through trained information specialists, support groups and up-to-date information regarding clinical trials.
The Patients Association is an independent patient charity campaigning for improvements in health and social care for patients. Through their helpline they support thousands of people each year with their concerns and queries about the health and social care system.
PAS provides information, help and support to sufferers of Pernicious Anaemia (PA), including their families and friends and strives to improve current and future diagnosis and treatment of Pernicious Anaemia.
The Sickle Cell Society believes that individuals with sickle cell disease have the right to quality care. This can only be achieved if funding is made available to educate health carers and other professionals about the condition.
The Thrombotic Thrombocytopenic Purpura (TTP) Network was established in 1998 by a TTP patient after receiving responses to an article she had written and published. It provides information for patients and a place for them to share their experiences.
As a health charity, the haemophilia society work to provide easy access to information and opportunities, influence national policy and practice to make the care and treatment of bleeding disorders consistent, effective and accessible to all and enable the voices of all people with bleeding disorders to be heard.
Thrombosis UK is a registered UK charity which provides a freely accessible site for those affected by the condition. It contains a wealth of practical information about the risks, prevention and treatment of venous thrombo-embolism. As an organisation, Thrombosis UK also offers Research Grants and Travel Fellowships for healthcare professionals and scientists.
The UK Thalassaemia Society has been in existence for more than 30 years and has amassed a wealth of experience in Thalassaemia not only in the UK, but through its network and associations with other countries.
UK's only charity focusing on support for patients, carers, doctors and nurses involved in the treatment of Waldenström's Macroglobulinemia (WM)
For over 50 years, the World Federation of Hemophilia (WFH) has provided global leadership to improve and sustain care for people with inherited bleeding disorders, including hemophilia, von Willebrand disease, rare factor deficiencies, and inherited platelet disorders.